You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 12, 2025

Drug Price Trends for HM CHILD LORATADINE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for HM CHILD LORATADINE

Average Pharmacy Cost for HM CHILD LORATADINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
HM CHILD LORATADINE 5 MG/5 ML 62011-0348-01 0.04181 ML 2024-03-20
HM CHILD LORATADINE 5 MG/5 ML 62011-0348-01 0.04249 ML 2024-02-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for HM CHILD LORATADINE

Market Overview

The global loratadine market, which includes products like HM CHILD LORATADINE, is experiencing significant growth driven by several key factors.

Increasing Prevalence of Allergic Disorders

The rising incidence of allergic disorders such as allergic rhinitis, urticaria, and seasonal allergies is a major driver of the loratadine market. According to the American Academy of Allergy, Asthma & Immunology, over 25.7% of people worldwide in the 18–44 age range experienced seasonal allergies in 2021, and hay fever affects more than 7.8% of Americans 18 and older[1].

Lifestyle Changes and Demographic Shifts

Changes in lifestyle and demographic shifts, particularly in high- and middle-income economies, are contributing to the increased demand for loratadine. The geriatric population, which is more susceptible to allergies, is also driving market growth[3][4].

Market Size and Growth Projections

  • The global loratadine market was valued at USD 163.2 billion in 2023 and is expected to grow at a CAGR of 3.1% from 2024 to 2033, reaching USD 221.4 billion by 2033[1].
  • For the loratadine syrup market specifically, it was valued at USD 150 million in 2021 and is expected to grow at a CAGR of 2% from 2022 to 2030[3].

Regional Analysis

North America

North America dominates the loratadine market, holding a 36.5% market revenue share in 2023. This region's strong healthcare infrastructure, high prevalence of allergies, and the presence of major pharmaceutical companies are key factors driving growth here[1][3][4].

Asia Pacific

The Asia Pacific region is expected to witness the fastest CAGR during the forecast period. Factors such as increasing awareness of allergic ailments, a rising geriatric population, and the prevalence of lifestyle diseases are driving growth in this region[4].

Segmentation and Trends

Dosage Forms and Indications

The loratadine market is segmented by dosage forms, including syrups, tablets, and other formulations. The syrup form, particularly, is popular due to its ease of administration, especially for pediatric patients and those who have difficulty swallowing tablets[3].

  • Urticaria and Allergic Rhinitis: Urticaria is expected to grow at the fastest rate among indications, driven by its direct correlation with the symptoms alleviated by loratadine syrup[3].

Branded vs. Generic

The generic category is expected to grow at the fastest rate due to its cost-effectiveness and easy availability. Generic manufacturers can offer the medication at a lower cost since they do not incur the same research and development expenses as branded manufacturers[3].

Distribution Channels

Online Pharmacies

The online pharmacy segment is expected to grow at the fastest CAGR during the forecast period. The integration of online pharmacy platforms with telemedicine and the large availability and accessibility of diverse product offerings are driving this segment's growth[4].

Price Projections and Accessibility

Cost-Effectiveness

Generic loratadine products, including syrups, are generally more cost-effective than their branded counterparts. This cost-effectiveness, combined with easy availability over-the-counter (OTC), enhances the market's growth potential[3].

Price Comparisons

While specific price comparisons for HM CHILD LORATADINE are not provided, the overall trend indicates that prices for loratadine products are expected to remain competitive due to the increasing presence of generic options and online pharmacies. Consumers can save up to 80% by comparing prices and using coupons at various pharmacies[2].

Consumer Preferences and Awareness

Non-Drowsy Formulations

The preference for non-drowsy formulations of loratadine is a significant factor driving market growth. Consumers increasingly seek medications that do not impair their daily activities, making non-drowsy loratadine a popular choice[1][3][4].

Awareness and Education

Government and organizational efforts to raise allergy awareness, such as World Allergy Week, are also contributing to the market's expansion. Increased awareness and diagnosis of allergies are leading to higher demand for effective treatments like loratadine[1].

Key Takeaways

  • The global loratadine market is driven by the increasing prevalence of allergic disorders and changing lifestyles.
  • North America is the largest market for loratadine, with significant growth expected in the Asia Pacific region.
  • Generic loratadine products are expected to grow at the fastest rate due to their cost-effectiveness.
  • Online pharmacies are becoming a key distribution channel, enhancing accessibility and affordability.
  • Non-drowsy formulations and ease of administration are critical factors influencing consumer preferences.

Frequently Asked Questions (FAQs)

Q: What is the current market size of the global loratadine market? A: The global loratadine market was valued at USD 163.2 billion in 2023[1].

Q: What is the expected CAGR of the global loratadine market from 2024 to 2033? A: The global loratadine market is expected to grow at a CAGR of 3.1% from 2024 to 2033[1].

Q: Which region dominates the loratadine market? A: North America dominates the loratadine market, holding a 36.5% market revenue share in 2023[1].

Q: Why is the generic category of loratadine expected to grow faster? A: The generic category is expected to grow faster due to its cost-effectiveness and easy availability, as generic manufacturers do not incur the same research and development expenses as branded manufacturers[3].

Q: What is the impact of online pharmacies on the loratadine market? A: Online pharmacies are expected to grow at the fastest CAGR, driven by their large availability, accessibility, and integration with telemedicine, making loratadine products more affordable and accessible[4].

Sources:

  1. The Brainy Insights: Loratadine Market Size, Share, Growth & Trends Report, 2033
  2. GoodRx: Compare Children's Loratadine Prices
  3. UnivDatos: Loratadine Syrup Market Analysis, Trends and Forecast 2022-2030
  4. Grand View Research: Loratadine Market Size, Share, Growth, Trends Report, 2030

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.